Ticker Details
Replimune Group, Inc.
IPO Date:	July 16, 2018
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1.39B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.60 | 3.97%
Avg Daily Range (30 D):	$0.83 | 9.44%
Avg Daily Range (90 D):	$0.55 | 8.81%

Institutional Daily Volume
Avg Daily Volume:	1.1M
Avg Daily Volume (30 D):	5.88M
Avg Daily Volume (90 D):	6.18M

Trade Size
Avg Trade Size (Sh.):	113
Avg Trade Size (Sh.) (30 D):	114
Avg Trade Size (Sh.) (90 D):	139

Institutional Trades
Total Institutional Trades:	2,571
Avg Institutional Trade:	$1.75M
Avg Institutional Trade (30 D):	$1.91M
Avg Institutional Trade (90 D):	$1.93M
Avg Institutional Trade Volume:	.14M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.85M
Avg Closing Trade (30 D):	$3.79M
Avg Closing Trade (90 D):	$2.92M
Avg Closing Volume:	144.18K

News

Aug 5, 2026 @ 9:52 PM Bragar Eagel & Squire, P.C. is Investigating Repli... Source: Bragar Eagel & Squire, P.C.

Jul 30, 2026 @ 10:15 PM Replimune Announces Favorable Outcome of FDA's Cel... Source: Na

Jul 30, 2026 @ 9:48 PM Bragar Eagel & Squire, P.C. is Investigating Repli... Source: Bragar Eagel & Squire, P.C.

May 18, 2026 @ 1:49 AM REPL Investors Have Opportunity to Join Replimune ... Source: Schall Law Firm

Apr 21, 2026 @ 8:14 AM Oncolytic Virus Immunotherapy Market Landscape Rep... Source: Researchandmarkets.Com

Financials
	TTM	Q1 2027	Q4 2026
Basic EPS	$-3.15	$-.72	$-.76
Diluted EPS	$-3.15	$-.72	$-.76
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-297.01M	$-69.77M	$-73.22M
Operating Income / Loss	$-297.74M	$-68.25M	$-73.34M
Cost of Revenue
Net Cash Flow	$87.98M	$-23.67M	$86.07M
PE Ratio

Splits
Dec 01, 2010	15:1